H.R. 3474, Hire More Heroes Act of 2014; H.R. 4438, American Research and Competitiveness Act of 2014; H.R. 4464, Permanent CFC Look-Through Act of 2014; S. 2260, EXPIRE Act; Administrations Tax Reform and 2015 Budget Proposals; Senate and House Committee Tax Reform Proposals; Proposals to reform domestic and international tax structures (no bills introduced); S. 2360, Stop Corporate Inversions Act of 2014; HR 4679, Stop Corporate Inversions Act of 2014;HR 3985, Stop Corporate Expatriation and Invest in Americas Infrastructure Act of 2014 Public Law 111-148, The Patient Protection and Affordable Care Act; Public Law 111-152, The Reconciliation Act of 2010; BPCIA (biosimilars); H.R. 3723, Viral Hepatitis Testing Act of 2013; Proposals to improve viral hepatitis screening and testing; H.R. 3204, Drug Quality & Security Act of 2013; S. 957, Drug Supply Chain Security Act; S. 621, Safe Prescribing Act of 2013; H. R. 1285, A bill to amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug;Discussions to clarify or reform the 340B program; Implementation of The Prescription Drug User Fee Act (PDUFA); Funding for State AIDS Drug Assistance programs under Ryan White Care Act; S. 1281, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014; H.R. 3547, Consolidated Appropriations Act, 2014; other Labor, Health and Human Services Appropriations; H.R. 2725, Food & Drug Administration Safety Over Sequestration Act of 2013; S. 1413, FDA User Fee Protection Act of 2013; FDAs Changes Being Effected Rule A variety of international trade issues including the Trade Promotion Authority, Trans-Pacific Partnership Agreement, Trans-Atlantic Trade and Investment Partnership Policies to enhance patient access to medicines in Medicare; Medicare payment proposals, S. 117 / H.R. 1102, Medicare Prescription Drug Price Negotiation Act of 2013; S. 740 / H.R. 1588, Medicare Drug Savings Act of 2013; H.R. 2925, Strengthening Medicare Anti-Fraud Measures Act of 2013; S. 1720, Patent Transparency and Improvements Act of 2013; H.R. 3309, Innovation Act; S. 214, Preserve Access to Affordable Generics Act of 2013; H.R. 3709, Protecting Consumer Access to Generic Drugs Act of 2013; H.R. 3116, MODDERN Cures Act of 2013; H.R. 2985, Combination Drug Development Incentive Act of 2013
TAX - Taxation/Internal Revenue Code HCR - Health Issues BUD - Budget/Appropriations TRD - Trade (domestic/foreign) MMM - Medicare/Medicaid CPT - Copyright/Patent/Trademark
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR)
ABBVIE, INC.
1399 New York Avenue NW, Suite 600, Washington, DC, 20005, US
MICHAEL D BOYD JOHN P. FORD ANDREW KAPLAN HEATHER STRAWN ADELE R WITENSTEIN MICHAEL D BOYD CATHERINE DRATZ FERGUSON JOHN P. FORD ANDREW KAPLAN HEATHER STRAWN ADELE R WITENSTEIN CATHERINE DRATZ FERGUSON JOHN P. FORD ANDREW KAPLAN HEATHER STRAWN CATHERINE DRATZ FERGUSON JOHN P. FORD ANDREW KAPLAN HEATHER STRAWN MICHAEL D BOYD JOHN P. FORD ANDREW KAPLAN ADELE R WITENSTEIN JOHN P. FORD HEATHER STRAWN ADELE R WITENSTEIN